Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

December 31, 2039

Study Completion Date

December 31, 2039

Conditions

Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study

Trial Locations (1)

RECRUITING

Science 37, Inc., Culver City

All Listed Sponsors

lead

Imugene Limited

INDUSTRY